Clinical Trial Update: Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating methylphenidate for cancer-related fatigue in pediatric brain tumor survivors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Cancer-related Fatigue

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Odense University Hospital | Conditions: Brain Tumor, Pediatric, Cancer-related Fatigue | Phase 3 | Status: RECRUITING